HomeAI · summaries
Storia in 5 fonti
Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts
Growing collaboration between multinational drug makers and Chinese companies not expected to slow after US move.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
theprint.in
Chinese pharma contractor under watch: Pentagon names WuXi AppTec on military list
The designation could threaten a key revenue stream for the drug contractor and complicate research, manufacturing and supply chains for American pharmaceutical firms.
- ·
fiercepharma.com
WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
After dodging a layer of U.S. scrutiny thus far, Chinese CDMO WuXi AppTec is back in the government’s crosshairs. The company is now listed in the U.S. | Inclusion on the…
- ·
cryptobriefing.com
Pentagon adds WuXi AppTec to military ties list, threatening access to $500B market
The Pentagon added WuXi AppTec to its Chinese military ties list, joining 188 entities. The biotech giant plans to contest the designation.
- ·
scmp.com
Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts
Growing collaboration between multinational drug makers and Chinese companies not expected to slow after US move.
- ·
China biotech firms say global push is ‘irreversible’ despite US barriers
Chinese drug makers are increasingly relying on overseas licensing deals to reach global markets amid growing geopolitical tensions.
- ·
Biotech firm WuXi sues US over allegations it supports China’s military
The company says it suffered substantial reputational and operational harm after being placed on a Pentagon blacklist.
- ·
straitstimes.com
Chinese pharma firm WuXi AppTec sues Pentagon over blacklisting
Among the other 80 companies on the blacklist were Alibaba, Baidu and BYD. Read more at straitstimes.com. Read more at straitstimes.com.